Companies in Medicon Valley are critically dependent on the presence of talent. But in order to attract talent we must improve a number of things including lower income tax, access to good international schools and willingness from all of us
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
Would you also like to build strong Life Science relations in the U.S, Japan or South Korea?
A cocktail of economic growth, a rapid shift to a more Western lifestyle and a growing population that is getting older has made South Korea one of Asia’s fastest growing pharmaceutical markets. The Korean medical market with 50 million people
IPR rules and issues in relation to the Korean market – is patenting different in Korea, compared to Europe and USA?
In the past couple of years we’ve seen clinical research move from the west to the east and the BRIC countries where they are competitive in not only price, but also time and quality. We have the chance to counter
Medicon Valley is facing increasing global competition and life science players in Medicon Valley need to find new smart ways to exploit the full potential of the region. This is the one of the conclusions which can be derived from
The agreement between the US State of Massachusetts and the Capital Region of Denmark, Region Zealand and Region Skåne was signed in June at the major BIO 2012 convention in Boston.
Leveraged by the Life Science Ambassador, Torsten Jepsen, Region Skåne, Region Zealand and The Capital Region of Denmark have now signed an agreement with Massachusetts, US, designed to strengthen and develop the collaboration between the two regions within life science.
A study by Danish Biotech shows that the main indicators, in order to attract venture capital, are global networks. Read the article at Børsen